Forte Biosciences, Inc.
FBRXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for FBRX. That does not mean none is planned.
Get an email about FBRX's next catalysts
Track Forte Biosciences (FBRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Forte Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Forte Biosciences, Inc.'s (FBRX) pipeline across Phase 2. Its lead program is FB-401 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Forte Biosciences, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Forte Biosciences, Inc. (FBRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track FBRX biotech catalysts?→
Add FBRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Forte Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.